230 related articles for article (PubMed ID: 14687660)
1. Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells.
Doan T; Farmer P; Cooney T; Ali MS
Cell Signal; 2004 Mar; 16(3):301-11. PubMed ID: 14687660
[TBL] [Abstract][Full Text] [Related]
2. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
Marrero MB; Venema VJ; Ju H; Eaton DC; Venema RC
Am J Physiol; 1998 Nov; 275(5):C1216-23. PubMed ID: 9814969
[TBL] [Abstract][Full Text] [Related]
3. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
Tang H; Zhao ZJ; Landon EJ; Inagami T
J Biol Chem; 2000 Mar; 275(12):8389-96. PubMed ID: 10722671
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase.
Shibasaki Y; Matsubara H; Nozawa Y; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
Hypertension; 2001 Sep; 38(3):367-72. PubMed ID: 11566906
[TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.
Matsubara H; Shibasaki Y; Okigaki M; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
Biochem Biophys Res Commun; 2001 Apr; 282(5):1085-91. PubMed ID: 11302725
[TBL] [Abstract][Full Text] [Related]
6. Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell.
Cui T; Nakagami H; Iwai M; Takeda Y; Shiuchi T; Daviet L; Nahmias C; Horiuchi M
Cardiovasc Res; 2001 Mar; 49(4):863-71. PubMed ID: 11230986
[TBL] [Abstract][Full Text] [Related]
7. Cytoskeletal remodeling in vascular smooth muscle cells in response to angiotensin II-induced activation of the SHP-2 tyrosine phosphatase.
Fernstrom K; Farmer P; Ali MS
J Cell Physiol; 2005 Dec; 205(3):402-13. PubMed ID: 16021628
[TBL] [Abstract][Full Text] [Related]
8. The protein-tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHO-AT1A cells.
Guillemot L; Levy A; Zhao ZJ; Bereziat G; Rothhut B
J Biol Chem; 2000 Aug; 275(34):26349-58. PubMed ID: 10843991
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.
Kim SO; Jiang J; Yi W; Feng GS; Frank SJ
J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080
[TBL] [Abstract][Full Text] [Related]
10. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
11. SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor.
Ali S; Nouhi Z; Chughtai N; Ali S
J Biol Chem; 2003 Dec; 278(52):52021-31. PubMed ID: 14522994
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
13. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II blocks nicotine-mediated neuroprotection against beta-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1.
Shaw S; Bencherif M; Marrero MB
J Neurosci; 2003 Dec; 23(35):11224-8. PubMed ID: 14657181
[TBL] [Abstract][Full Text] [Related]
15. Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells.
Tang H; Zhao ZJ; Huang XY; Landon EJ; Inagami T
J Biol Chem; 1999 Apr; 274(18):12401-7. PubMed ID: 10212213
[TBL] [Abstract][Full Text] [Related]
16. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
17. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.
Ushio-Fukai M; Zuo L; Ikeda S; Tojo T; Patrushev NA; Alexander RW
Circ Res; 2005 Oct; 97(8):829-36. PubMed ID: 16151024
[TBL] [Abstract][Full Text] [Related]
18. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.
Tabet F; Schiffrin EL; Callera GE; He Y; Yao G; Ostman A; Kappert K; Tonks NK; Touyz RM
Circ Res; 2008 Jul; 103(2):149-58. PubMed ID: 18566342
[TBL] [Abstract][Full Text] [Related]
19. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
20. Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells.
Wu L; Iwai M; Li Z; Shiuchi T; Min LJ; Cui TX; Li JM; Okumura M; Nahmias C; Horiuchi M
Mol Endocrinol; 2004 Mar; 18(3):666-78. PubMed ID: 14684844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
